Investing.com - Novartis ADR (NYSE: NVS) reported third quarter EPS of $2.06, $0.12 better than the analyst estimate of $1.94. Revenue for the quarter came in at $12.82B versus the consensus estimate of $12.79B.
Novartis ADR's stock price closed at $115.63. It is up 3.15% in the last 3 months and up 23.33% in the last 12 months.
Novartis ADR saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Novartis ADR's stock price’s past reactions to earnings here.
According to InvestingPro, Novartis ADR's Financial Health score is "great performance".
Check out Novartis ADR's recent earnings performance, and Novartis ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.